Treatment With TNX-102 SL Produces Clinically Meaningful Improvements in Patient-Centered Outcomes in Fibromyalgia
Tonmya® (TNX-102 SL; Cyclobenzaprine HCI Sublingual Tablets [CBP SL]) for the Treatment of Adults With Fibromyalgia: Number Needed to Treat, Number Needed to Harm and Likelihood to be Helped or Harmed: Results from a Pooled Analysis of Two Phase 3 Studies
